* Gamida Cell Ltd GMDA.OQ GMDA.O is expected to show no
change
in quarterly revenue when it reports results on May 2
(estimated).
* Refinitiv's mean analyst estimate for Gamida Cell Ltd is
for a
loss of 34 cents per share. For the same quarter last year, the
company reported a loss of 31 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had risen by
about 4.0%
in the last three months.
* Wall Street's median 12-month price target for Gamida Cell
Ltd
is $14, above its last closing price of $2.67.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2021 -0.40 -0.40 -0.52 Missed -28.4
Sep. 30 2021 -0.49 -0.48 -0.33 Beat 31.3
Jun. 30 2021 -0.39 -0.40 -0.36 Beat 10.4
Mar. 31 2021 -0.40 -0.40 -0.31 Beat 22.2
Dec. -0.34 -0.34 -0.68 Missed -98.1
31 2020
Sep. 30 2020 -0.31 -0.31 -0.30 Beat 4.3
Jun. 30 2020 -0.30 -0.30 -0.37 Missed -24.7
Mar. 31 2020 -0.45 -0.45 -0.27 Beat 39.7
This summary was machine generated April 29 at 18:31 GMT. All
figures in US dollars unless otherwise stated